All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-MV-01LX093 | Anti-CAIX (G119) h(CD28-CD3ζ) CAR, pMMLV | Human | G119 | human | scFv-CD28-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX094 | Anti-CAIX (MSC8) h(CD28-CD3ζ) CAR, pMMLV | Human | MSC8 | human | scFv-CD28-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX095 | Anti-CAIX (G250) h(CD28-CD3ζ) CAR, pMMLV | Human | G250 | Mouse | scFv-CD28-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX096 | Anti-CAIX (5C9B7) h(CD28-CD3ζ) CAR, pMMLV | Human | 5C9B7 | Mouse | scFv-CD28-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX097 | Anti-CAIX (G36) h(CD28-CD3ζ) CAR, pMMLV | Human | G36 | Mouse | scFv-CD28-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX098 | Anti-CAIX (6F7A5) h(CD28-CD3ζ) CAR, pMMLV | Human | 6F7A5 | Mouse | scFv-CD28-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX338 | Anti-CAIX (G119) h(41BB-CD3ζ) CAR, pMMLV | Human | G119 | human | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX339 | Anti-CAIX (MSC8) h(41BB-CD3ζ) CAR, pMMLV | Human | MSC8 | human | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX340 | Anti-CAIX (G250) h(41BB-CD3ζ) CAR, pMMLV | Human | G250 | Mouse | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX341 | Anti-CAIX (5C9B7) h(41BB-CD3ζ) CAR, pMMLV | Human | 5C9B7 | Mouse | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX342 | Anti-CAIX (G36) h(41BB-CD3ζ) CAR, pMMLV | Human | G36 | Mouse | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-MV-01LX343 | Anti-CAIX (6F7A5) h(41BB-CD3ζ) CAR, pMMLV | Human | 6F7A5 | Mouse | scFv-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
CAR-SB-02LX090 | Anti-CAIX (G119) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | Human | G119 | human | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX091 | Anti-CAIX (MSC8) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | Human | MSC8 | human | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX092 | Anti-CAIX (G250) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | Human | G250 | Mouse | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX093 | Anti-CAIX (5C9B7) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | Human | 5C9B7 | Mouse | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX094 | Anti-CAIX (G36) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | Human | G36 | Mouse | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX095 | Anti-CAIX (6F7A5) h(CD28-41BB-CD3ζ) CAR, pSBCAR1 | Human | 6F7A5 | Mouse | scFv-CD28-41BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX574 | Anti-CAIX (G119) h(ICOS-4-1BB-CD3ζ) CAR, pSBCAR1 | Human | G119 | human | scFv-ICOS-4-1BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
CAR-SB-02LX575 | Anti-CAIX (MSC8) h(ICOS-4-1BB-CD3ζ) CAR, pSBCAR1 | Human | MSC8 | human | scFv-ICOS-4-1BB-CD3ζ | Sleeping Beauty (SB) transposon | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION